A detailed history of Northern Trust Corp transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 55,026 shares of CODX stock, worth $68,782. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,026
Previous 55,250 0.41%
Holding current value
$68,782
Previous $73,000 16.44%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$1.06 - $1.42 $237 - $318
-224 Reduced 0.41%
55,026 $61,000
Q3 2023

Nov 13, 2023

SELL
$1.03 - $1.85 $759 - $1,363
-737 Reduced 1.32%
55,250 $58,000
Q2 2023

Aug 11, 2023

SELL
$1.04 - $1.64 $6,425 - $10,131
-6,178 Reduced 9.94%
55,987 $62,000
Q1 2023

May 15, 2023

BUY
$1.39 - $3.24 $782 - $1,824
563 Added 0.91%
62,165 $92,000
Q4 2022

Feb 13, 2023

BUY
$2.32 - $3.68 $12,755 - $20,232
5,498 Added 9.8%
61,602 $155,000
Q3 2022

Nov 14, 2022

BUY
$2.87 - $7.01 $14,981 - $36,592
5,220 Added 10.26%
56,104 $180,000
Q2 2022

Aug 12, 2022

BUY
$3.76 - $6.29 $14,227 - $23,801
3,784 Added 8.03%
50,884 $286,000
Q1 2022

May 13, 2022

SELL
$5.03 - $9.61 $7,610 - $14,539
-1,513 Reduced 3.11%
47,100 $291,000
Q4 2021

Feb 08, 2022

SELL
$8.12 - $10.37 $3,337 - $4,262
-411 Reduced 0.84%
48,613 $434,000
Q3 2021

Nov 15, 2021

SELL
$7.48 - $11.38 $5,505 - $8,375
-736 Reduced 1.48%
49,024 $477,000
Q2 2021

Aug 13, 2021

SELL
$7.16 - $9.56 $1.7 Million - $2.27 Million
-237,339 Reduced 82.67%
49,760 $410,000
Q1 2021

May 12, 2021

SELL
$8.52 - $19.21 $165,092 - $372,232
-19,377 Reduced 6.32%
287,099 $2.74 Million
Q4 2020

Feb 11, 2021

BUY
$9.3 - $15.19 $29,322 - $47,894
3,153 Added 1.04%
306,476 $2.85 Million
Q3 2020

Nov 16, 2020

SELL
$8.24 - $30.8 $34,706 - $129,729
-4,212 Reduced 1.37%
303,323 $4.12 Million
Q2 2020

Aug 14, 2020

BUY
$7.46 - $23.42 $2.14 Million - $6.72 Million
287,044 Added 1400.83%
307,535 $5.95 Million
Q1 2020

May 14, 2020

BUY
$0.91 - $17.81 $18,646 - $364,944
20,491 New
20,491 $156,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $42.2M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.